Why Is Accolade Stock Trading Over 100% On Tuesday?

Transcarent agreed to buy Accolade Inc ACCD Wednesday for $621 million.The purchase price works out to $7.03 per share in cash.Accolade is a Personalized Healthcare company that offers employer, health plan, and consumer solutions combined with virtual primary care and mental health, medical opinion, and care navigation.The transaction is expected to bring Transcarent’s generative AI-powered WayFinding and comprehensive care experiences — Cancer Care, Surgery Care, and Weight Health — along with its Pharmac ...